[Effect of morphine in cancer pain].Gan No Rinsho. 1989 Jan; 35(1):51-4.GN
Abstract
The usefulness of oral morphine to alleviate pain has been tested in 70 patients with cancer. The efficacy was found to be 87% (61/70). The starting dose was 10 mg/d-12 mg/d (mean 36 mg/d), and the maximum dose was 10 mg/d-3,600 mg/d. Twenty four of these patients were able to stay at home or go to the hospital for dose treatment. In 27 patients, oral morphine dose were able to administrated until death. Although vomiting and constipation were frequent side effects, the administration of adjuvant drugs relieved these symptoms. It was found that these oral morphine doses did not shorten a patient's life span. Thus we have concluded that oral morphine proved a useful, safe, and convenient drug for the control of cancer pain.
Links
MeSH
Pub Type(s)
English Abstract
Journal Article
Research Support, Non-U.S. Gov't
Language
jpn
PubMed ID
2921810
Citation
Nukariya, N, et al. "[Effect of Morphine in Cancer Pain]." Gan No Rinsho. Japan Journal of Cancer Clinics, vol. 35, no. 1, 1989, pp. 51-4.
Nukariya N, Nishiwaki Y, Kodama T, et al. [Effect of morphine in cancer pain]. Gan No Rinsho. 1989;35(1):51-4.
Nukariya, N., Nishiwaki, Y., Kodama, T., Inoue, Y., Hayashibe, A., Murasugi, M., Kuroki, M., Takahashi, K., Nishiyama, Y., & Kitaya, T. (1989). [Effect of morphine in cancer pain]. Gan No Rinsho. Japan Journal of Cancer Clinics, 35(1), 51-4.
Nukariya N, et al. [Effect of Morphine in Cancer Pain]. Gan No Rinsho. 1989;35(1):51-4. PubMed PMID: 2921810.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - [Effect of morphine in cancer pain].
A1 - Nukariya,N,
AU - Nishiwaki,Y,
AU - Kodama,T,
AU - Inoue,Y,
AU - Hayashibe,A,
AU - Murasugi,M,
AU - Kuroki,M,
AU - Takahashi,K,
AU - Nishiyama,Y,
AU - Kitaya,T,
PY - 1989/1/1/pubmed
PY - 1989/1/1/medline
PY - 1989/1/1/entrez
SP - 51
EP - 4
JF - Gan no rinsho. Japan journal of cancer clinics
JO - Gan No Rinsho
VL - 35
IS - 1
N2 - The usefulness of oral morphine to alleviate pain has been tested in 70 patients with cancer. The efficacy was found to be 87% (61/70). The starting dose was 10 mg/d-12 mg/d (mean 36 mg/d), and the maximum dose was 10 mg/d-3,600 mg/d. Twenty four of these patients were able to stay at home or go to the hospital for dose treatment. In 27 patients, oral morphine dose were able to administrated until death. Although vomiting and constipation were frequent side effects, the administration of adjuvant drugs relieved these symptoms. It was found that these oral morphine doses did not shorten a patient's life span. Thus we have concluded that oral morphine proved a useful, safe, and convenient drug for the control of cancer pain.
SN - 0021-4949
UR - https://www.unboundmedicine.com/medline/citation/2921810/[Effect_of_morphine_in_cancer_pain]_
L2 - https://www.medicalonline.jp/meteo_linkout.php?issn=0021-4949&volume=35&issue=1&spage=51
DB - PRIME
DP - Unbound Medicine
ER -